Fecal Calprotectin Testing Market Size

  • Report ID: 4060
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Fecal Calprotectin Testing Market Size

Fecal Calprotectin Testing Market size was valued at USD 145.44 million in 2024 and is set to reach USD 473.1 million by the end of 2037, expanding at around 10.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of fecal calprotectin testing is assessed at USD 158.24 million.

The growth of the market can be attributed to the increasing prevalence of colon rectum cancer, inflammatory bowel syndrome, and other gastrointestinal disorders, as the fecal calprotectin test is used for the diagnosis of these diseases. The recent statistics revealed by the World Health Organization stated that colon and rectum cancer was considered to be one of the most prevalent cancers across the globe, with around 1.93 million cases being diagnosed worldwide in 2020, and taking approximately 916,000 lives in the same year.

In addition to the aforementioned factors, the other factors that are expected to expand the market size are the rising cases of cancers in small and large intestines. Also, the rising prevalence of inflammatory bowel disease, celiac disease, colorectal cancer, and other problems among the global population is expected to generate a demand for fecal calprotectin testing. Also, the indulgence in unhealthy lifestyles and consumption of junk food items has propelled the development of severe gastrointestinal illnesses across the globe which is a positive indicator for a high utilization rate of fecal calprotectin testing in the upcoming years. Furthermore, the rapid growth of the healthcare industry along with the presence of technologically developed facilities including e-prescribing is anticipated to ease the process of fecal calprotectin testing.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4060
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fecal calprotectin testing is assessed at USD 158.24 million.

The fecal calprotectin testing market size was valued at USD 145.44 million in 2024 and is set to reach USD 473.1 million by the end of 2037, expanding at around 10.9% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of colorectal cancer and other gastrointestinal diseases will boost the market growth.

North America is projected to hold the largest industry share by 2037, propelled by increasing frequency of colorectal cancer, celiac disease, and other disorders in developed countries.

The major players in the market include Exelixis Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample